All Stories

  1. Identified the key target cell type for strategies to prevent atherosclerosis in progeria

    Article • Proceedings of the National Academy of Sciences, April 2024, Proceedings of the National Academy of Sciences

    Prof. Vicente Andrés

  2. Aging and Vascular Disease: A Multidisciplinary Overview

    Article • Journal of Clinical Medicine, August 2023, MDPI AG

    Prof. Vicente Andrés

  3. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction

    Article • International Journal of Molecular Sciences, July 2023, MDPI AG

    Prof. Vicente Andrés

  4. Lamin A/C Ablation in Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction: Role in the Pathophysiology of LMNA-Related Dilated Cardiomyopathies

    Article • June 2023, MDPI AG

    Prof. Vicente Andrés

  5. Emerging roles of interferon-stimulated gene-15 in age-related telomere attrition, the DNA damage response, and cardiovascular disease

    Article • Frontiers in Cell and Developmental Biology, March 2023, Frontiers

    Prof. Vicente Andrés

  6. Analysis of Monocyte Recruitment During Inflammation by Intravital Imaging

    Article • January 2023, Springer Science + Business Media

    Prof. Vicente Andrés

  7. Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry

    Article • International Journal of Molecular Sciences, October 2022, MDPI AG

    Prof. Vicente Andrés

  8. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome

    Article • Circulation, November 2021, Wolters Kluwer Health

    Prof. Vicente Andrés

  9. Targeting Tyrosine Hydroxylase for Abdominal Aortic Aneurysm: Impact on Inflammation, Oxidative Stress, and Vascular Remodeling

    Article • Hypertension, September 2021, Wolters Kluwer Health

    Prof. Vicente Andrés

  10. Genomic instability in the naturally and prematurely aged myocardium

    Article • Proceedings of the National Academy of Sciences, August 2021, Proceedings of the National Academy of Sciences

    Prof. Vicente Andrés

  11. Progression of Early Subclinical Atherosclerosis (PESA) Study

    Article • Journal of the American College of Cardiology, July 2021, Elsevier

    Prof. Vicente Andrés

  12. Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson–Gilford Progeria Syndrome

    Article • ACS Central Science, June 2021, American Chemical Society (ACS)

    Prof. Vicente Andrés

  13. Triglycerides and Residual Atherosclerotic Risk

    Article • Journal of the American College of Cardiology, June 2021, Elsevier

    Prof HECTOR BUENO, Prof. Vicente Andrés

  14. Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models

    Article • Cells, May 2021, MDPI AG

    Prof. Vicente Andrés

  15. The progeria research foundation 10th international scientific workshop; researching possibilities, ExTENding lives – webinar version scientific summary

    Article • Aging, March 2021, Impact Journals, LLC

    Prof. Vicente Andrés

  16. Rolipram Prevents the Formation of Abdominal Aortic Aneurysm (AAA) in Mice: PDE4B as a Target in AAA

    Article • Antioxidants, March 2021, MDPI AG

    Prof. Vicente Andrés

  17. Telomerase as a Therapeutic Target in Cardiovascular Disease

    Article • Arteriosclerosis Thrombosis and Vascular Biology, March 2021, Wolters Kluwer Health

    Prof. Vicente Andrés

  18. Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson–Gilford progeria syndrome

    Article • Cardiovascular Research, February 2021, Oxford University Press (OUP)

    Professor Jose Jalife, Prof. Vicente Andrés

  19. Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson–Gilford Progeria Syndrome with Ldlr Deficiency

    Article • Cells, October 2020, MDPI AG

    Prof. Vicente Andrés

  20. Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals

    Article • Journal of the American College of Cardiology, October 2020, Elsevier

    Prof HECTOR BUENO, Prof. Vicente Andrés

  21. Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis

    Article • Cells, September 2020, MDPI AG

    Prof. Vicente Andrés

  22. Identification of common cardiometabolic alterations and deregulated pathways in mouse and pig models of aging

    Article • Aging Cell, July 2020, Wiley

    Prof. Vicente Andrés

  23. The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis

    Article • Scientific Reports, July 2020, Springer Science + Business Media

    Prof. Vicente Andrés

  24. Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart

    Article • Cardiovascular Research, July 2020, Oxford University Press (OUP)

    Prof. Vicente Andrés

  25. miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis

    Article • Haematologica, June 2020, Ferrata Storti Foundation (Haematologica)

    Prof. Vicente Andrés

  26. Short-Term Progression of Multiterritorial Subclinical Atherosclerosis

    Article • Journal of the American College of Cardiology, April 2020, Elsevier

    Prof HECTOR BUENO, Prof. Vicente Andrés

  27. Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment

    Article • Cells, March 2020, MDPI AG

    Prof. Vicente Andrés

  28. Biological Versus Chronological Aging

    Article • Journal of the American College of Cardiology, March 2020, Elsevier

    Prof. Vicente Andrés

  29. Endothelial MT 1‐ MMP targeting limits intussusceptive angiogenesis and colitis via TSP1/nitric oxide axis

    Article • EMBO Molecular Medicine, December 2019, Springer Science + Business Media

    Prof. Vicente Andrés

  30. Lamin A/C deficiency in CD4+ T‐cells enhances regulatory T‐cells and prevents inflammatory bowel disease

    Article • The Journal of Pathology, October 2019, Wiley

    Prof. Vicente Andrés

  31. Remodeling of Bone Marrow Hematopoietic Stem Cell Niches Promotes Myeloid Cell Expansion during Premature or Physiological Aging

    Article • Cell Stem Cell, September 2019, Elsevier

    Prof. Vicente Andrés

  32. Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice

    Article • Journal of Molecular and Cellular Cardiology, July 2019, Elsevier

    Prof. Vicente Andrés

  33. Generation and characterization of a novel knockin minipig model of Hutchinson-Gilford progeria syndrome

    Article • Cell Discovery, March 2019, Springer Science + Business Media

    Prof. Vicente Andrés

  34. Vascular smooth muscle cell‐specific progerin expression in a mouse model of Hutchinson–Gilford progeria syndrome promotes arterial stiffness: Therapeutic effect of dietary nitrite

    Article • Aging Cell, March 2019, Wiley

    Prof. Vicente Andrés

  35. Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells

    Article • EMBO Molecular Medicine, March 2019, Springer Science + Business Media

    Prof. Vicente Andrés

  36. Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome

    Article • Nucleus, January 2019, Taylor & Francis

    Prof. Vicente Andrés

  37. Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM‐1

    Article • The FASEB Journal, November 2018, Wiley

    Dr Paloma Martin-Sanz, Dr Cristina Rodriguez, Silvia Gonzalez-Ramos, Miguel Angel Lasuncion, Prof. Vicente Andrés

  38. Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification

    Article • Atherosclerosis, November 2018, Elsevier

    Jose A. Rodriguez, Prof. Vicente Andrés

  39. The microRNA-29/PGC1α regulatory axis is critical for metabolic control of cardiac function

    Article • PLoS Biology, October 2018, PLOS

    Prof HECTOR BUENO, Prof. Vicente Andrés

  40. Accelerated atherosclerosis in HGPS

    Article • Aging, October 2018, Impact Journals, LLC

    Prof. Vicente Andrés

  41. Electrocardiographic Abnormalities in Patients With Hutchinson-Gilford Progeria Syndrome

    Article • JAMA Cardiology, October 2018, American Medical Association (AMA)

    Prof. Vicente Andrés

  42. Telomere Length as Cardiovascular Aging Biomarker

    Article • Journal of the American College of Cardiology, August 2018, Elsevier

    Prof. Vicente Andrés

  43. Vascular Smooth Muscle–Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome

    Article • Circulation, July 2018, Wolters Kluwer Health

    Prof. Vicente Andrés

  44. miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis

    Article • PLoS ONE, June 2018, PLOS

    Prof. Vicente Andrés

  45. MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis

    Article • Nature Communications, March 2018, Springer Science + Business Media

    Dr Cristina Rodriguez, Prof. Vicente Andrés

  46. Mecanismos de envejecimiento vascular: ¿Qué podemos aprender del síndrome de progeria de Hutchinson-Gilford?

    Article • Clínica e Investigación en Arteriosclerosis, March 2018, Elsevier

    Dr Cristina Rodriguez, Prof. Vicente Andrés

  47. Defective p27 phosphorylation at serine 10 affects vascular reactivity and increases abdominal aortic aneurysm development via Cox-2 activation

    Article • Journal of Molecular and Cellular Cardiology, March 2018, Elsevier

    Prof. Vicente Andrés

  48. Aging in the Cardiovascular System: Lessons from Hutchinson-Gilford Progeria Syndrome

    Article • Annual Review of Physiology, February 2018, Annual Reviews

    Prof. Vicente Andrés

  49. Lamin A/C augments Th1 differentiation and response against vaccinia virus and Leishmania major

    Article • Cell Death and Disease, January 2018, Springer Science + Business Media

    Prof. Vicente Andrés

  50. Current State of Basic and Translational Cardiovascular Research in Spain

    Article • Circulation Research, October 2017, Wolters Kluwer Health

    Prof. Vicente Andrés

  51. A-type lamins and cardiovascular disease in premature aging syndromes

    Article • Current Opinion in Cell Biology, June 2017, Elsevier

    Prof. Vicente Andrés

  52. Novel phosphate-activated macrophages prevent ectopic calcification by increasing extracellular ATP and pyrophosphate

    Article • PLoS ONE, March 2017, PLOS

    Prof. Vicente Andrés

  53. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice

    Article • Science, February 2017, American Association for the Advancement of Science

    Prof. Vicente Andrés

  54. Proteomics Research in Cardiovascular Medicine and Biomarker Discovery

    Article • Journal of the American College of Cardiology, December 2016, Elsevier

    Prof. Vicente Andrés

  55. Cardiac electrical defects in progeroid mice and Hutchinson–Gilford progeria syndrome patients with nuclear lamina alterations

    Article • Proceedings of the National Academy of Sciences, October 2016, Proceedings of the National Academy of Sciences

    Prof. Vicente Andrés

  56. The CNIC

    Article • Circulation Research, September 2016, Wolters Kluwer Health

    Prof. Vicente Andrés

  57. Nestin+ cells direct inflammatory cell migration in atherosclerosis

    Article • Nature Communications, September 2016, Nature

    Jose Martinez Gonzalez, Dr Cristina Rodriguez, Prof. Vicente Andrés

  58. Endothelial Jag1-RBPJ signalling promotes inflammatory leucocyte recruitment and atherosclerosis

    Article • Cardiovascular Research, August 2016, European Society of Cardiology

    Dr Cristina Rodriguez, Prof. Vicente Andrés

  59. Alternatively activated macrophages exhibit an anticalcifying activity dependent on extracellular ATP/pyrophosphate metabolism

    Article • AJP Cell Physiology, May 2016, American Physiological Society

    Prof. Vicente Andrés

  60. A Novel Systems-Biology Algorithm for the Analysis of Coordinated Protein Responses Using Quantitative Proteomics

    Article • Molecular & Cellular Proteomics, May 2016, Elsevier

    Prof. Vicente Andrés

  61. Short Telomere Load, Telomere Length, and Subclinical Atherosclerosis

    Article • Journal of the American College of Cardiology, May 2016, Elsevier

    Prof. Vicente Andrés

  62. ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression

    Article • Thrombosis and Haemostasis, November 2015, Thieme Publishing Group

    Prof. Vicente Andrés

  63. Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, September 2015, Elsevier

    Prof. Vicente Andrés

  64. Loss of p27 phosphorylation at Ser10 accelerates early atherogenesis by promoting leukocyte recruitment via RhoA/ROCK

    Article • Journal of Molecular and Cellular Cardiology, July 2015, Elsevier

    Prof. Vicente Andrés

  65. Impact of estrogens on atherosclerosis and bone in the apolipoprotein E–deficient mouse model

    Article • Menopause, April 2015, Wolters Kluwer Health

    Prof. Vicente Andrés

  66. Targeting γ-secretases protect against angiotensin II-induced cardiac hypertrophy

    Article • Journal of Hypertension, April 2015, Wolters Kluwer Health

    Prof. Vicente Andrés

  67. ADAMTS7 in Cardiovascular Disease

    Article • Circulation, March 2015, Wolters Kluwer Health

    Prof. Vicente Andrés

  68. In Vitro Macrophage Phagocytosis Assay

    Article • January 2015, Springer Science + Business Media

    Prof. Vicente Andrés

  69. Isolation of Mouse Primary Aortic Endothelial Cells by Selection with Specific Antibodies

    Article • January 2015, Springer Science + Business Media

    Prof. Vicente Andrés

  70. Oil Red O and Hematoxylin and Eosin Staining for Quantification of Atherosclerosis Burden in Mouse Aorta and Aortic Root

    Article • January 2015, Springer Science + Business Media

    Prof. Vicente Andrés

  71. Sorting Nexin 6 Enhances Lamin A Synthesis and Incorporation into the Nuclear Envelope

    Article • PLoS ONE, December 2014, PLOS

    Prof. Vicente Andrés

  72. Vitamin D puts the brakes on angiotensin II-induced oxidative stress and vascular smooth muscle cell senescence

    Article • Atherosclerosis, October 2014, Elsevier

    Prof. Vicente Andrés

  73. Nuclear Envelope Lamin-A Couples Actin Dynamics with Immunological Synapse Architecture and T Cell Activation

    Article • Science Signaling, April 2014, American Association for the Advancement of Science

    Dr Laia Trigueros Motos, Prof. Vicente Andrés

  74. Polμ Deficiency Increases Resistance to Oxidative Damage and Delays Liver Aging

    Article • PLoS ONE, April 2014, PLOS

    Prof. Vicente Andrés

  75. High-Resolution Imaging of Intravascular Atherogenic Inflammation in Live Mice

    Article • Circulation Research, February 2014, Wolters Kluwer Health

    Prof. Vicente Andrés

  76. Age-dependent defective TGF-beta1 signaling in patients undergoing coronary artery bypass grafting

    Article • Journal of Cardiothoracic Surgery, February 2014, Springer Science + Business Media

    Prof. Vicente Andrés

  77. Genetic Variants in CCNB1 Associated With Differential Gene Transcription and Risk of Coronary In-Stent Restenosis

    Article • Circulation Cardiovascular Genetics, February 2014, Wolters Kluwer Health

    Prof. Vicente Andrés

  78. A major role for RCAN1 in atherosclerosis progression

    Article • EMBO Molecular Medicine, October 2013, EMBO

    Jose Martinez Gonzalez, Dr Cristina Rodriguez, Prof. Vicente Andrés

  79. PI3K p110γ Deletion Attenuates Murine Atherosclerosis by Reducing Macrophage Proliferation but Not Polarization or Apoptosis in Lesions

    Article • PLoS ONE, August 2013, PLOS

    Prof. Vicente Andrés

  80. Snake venomics of Lachesis muta rhombeata and genus-wide antivenomics assessment of the paraspecific immunoreactivity of two antivenoms evidence the high compositional and immunological conservation across Lachesis

    Article • Journal of Proteomics, August 2013, Elsevier

    Juan Calvete, Prof. Vicente Andrés

  81. Defective Extracellular Pyrophosphate Metabolism Promotes Vascular Calcification in a Mouse Model of Hutchinson-Gilford Progeria Syndrome That Is Ameliorated on Pyrophosphate Treatment

    Article • Circulation, June 2013, Wolters Kluwer Health

    Prof. Vicente Andrés

  82. Aryl hydrocarbon receptor contributes to the MEK/ERK-dependent maintenance of the immature state of human dendritic cells

    Article • Blood, April 2013, American Society of Hematology

    Prof. Vicente Andrés

  83. Embryological-Origin-Dependent Differences in Homeobox Expression in Adult Aorta: Role in Regional Phenotypic Variability and Regulation of NF- B Activity

    Article • Arteriosclerosis Thrombosis and Vascular Biology, February 2013, Wolters Kluwer Health

    Dr Laia Trigueros Motos, Prof. Vicente Andrés

  84. Inactivation of Nuclear Factor-Y Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation

    Article • Arteriosclerosis Thrombosis and Vascular Biology, February 2013, Wolters Kluwer Health

    Jose Martinez Gonzalez, Dr Cristina Rodriguez, Prof. Vicente Andrés

  85. Role of c-MYC in tumor-associated macrophages and cancer progression

    Article • OncoImmunology, February 2013, Taylor & Francis

    Prof. Vicente Andrés

  86. Increased dosage ofInk4/Arfprotects against glucose intolerance and insulin resistance associated with aging

    Article • Aging Cell, December 2012, Wiley

    Prof. Vicente Andrés

  87. Macrophage proliferation and apoptosis in atherosclerosis

    Article • Current Opinion in Lipidology, October 2012, Wolters Kluwer Health

    Prof. Vicente Andrés

  88. In Vivo Inhibition of c-MYC in Myeloid Cells Impairs Tumor-Associated Macrophage Maturation and Pro-Tumoral Activities

    Article • PLoS ONE, September 2012, PLOS

    Prof. Vicente Andrés

  89. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis

    Article • Platelets, June 2012, Taylor & Francis

    Prof. Vicente Andrés

  90. Limus Is Not Limus—A Proposal to Adjust Terminology in the Context of Drug-eluting Stents

    Article • Journal of Cardiovascular Pharmacology, May 2012, Wolters Kluwer Health

    Prof. Vicente Andrés

  91. Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice

    Article • Atherosclerosis, March 2012, Elsevier

    Prof. Vicente Andrés

  92. The promoter activity of human Mfn2 depends on Sp1 in vascular smooth muscle cells

    Article • Cardiovascular Research, January 2012, European Society of Cardiology

    Prof. Vicente Andrés

  93. Synthesis, transport and incorporation into the nuclear envelope of A-type lamins and inner nuclear membrane proteins

    Article • Biochemical Society Transactions, November 2011, Portland Press Ltd.

    Prof. Vicente Andrés

  94. A glimpse on the phenomenon of macrophage polarization during atherosclerosis

    Article • Immunobiology, November 2011, Elsevier

    Prof. Vicente Andrés

  95. Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging

    Article • Science Translational Medicine, October 2011, American Association for the Advancement of Science

    Prof. Vicente Andrés

  96. Deficient p27 Phosphorylation at Serine 10 Increases Macrophage Foam Cell Formation and Aggravates Atherosclerosis Through a Proliferation-Independent Mechanism

    Article • Arteriosclerosis Thrombosis and Vascular Biology, September 2011, Wolters Kluwer Health

    Dr Antonio Diez-Juan, Jose Martinez Gonzalez, Dr Cristina Rodriguez, Prof. Vicente Andrés

  97. Insulin Receptor Substrate-1 Expression Is Increased in Circulating Leukocytes of Patients with Acute Coronary Syndrome

    Article • ISRN Cardiology, January 2011, Hindawi Publishing Corporation

    Prof HECTOR BUENO, Prof. Vicente Andrés

  98. A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy

    Article • Frontiers in Bioscience-Scholar, January 2011, IMR Press

    Prof. Vicente Andrés

  99. ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma–lamin A complexes

    Article • The Journal of Cell Biology, November 2010, Rockefeller University Press

    Prof. Vicente Andrés

  100. A role for miR-33 in p53 regulation: New perspectives for hematopoietic stem cell research

    Article • Cell Cycle, September 2010, Taylor & Francis

    Prof. Vicente Andrés

  101. Tumor suppressor p27Kip1 undergoes endolysosomal degradation through its interaction with sorting nexin 6

    Article • The FASEB Journal, August 2010, Federation of American Societies For Experimental Biology (FASEB)

    Dr Marcel Verges, Prof. Vicente Andrés

  102. p19ARFDeficiency Reduces Macrophage and Vascular Smooth Muscle Cell Apoptosis and Aggravates Atherosclerosis

    Article • Journal of the American College of Cardiology, May 2010, Elsevier

    Prof. Vicente Andrés

  103. Control of cell proliferation in atherosclerosis: insights from animal models and human studies

    Article • Cardiovascular Research, November 2009, European Society of Cardiology

    Prof. Vicente Andrés

  104. Molecular Mechanisms of Atherosclerosis in Metabolic Syndrome

    Article • Arteriosclerosis Thrombosis and Vascular Biology, December 2008, Wolters Kluwer Health

    Prof. Vicente Andrés

  105. Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope

    Article • The Journal of Cell Biology, November 2008, Rockefeller University Press

    Prof. Vicente Andrés

  106. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69

    Article • Cardiovascular Research, August 2008, European Society of Cardiology

    Prof. Vicente Andrés

  107. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation

    Article • Cardiovascular Research, November 2007, European Society of Cardiology

    Juan Calvete, Prof. Vicente Andrés

  108. Telomere dysfunction in hypertension

    Article • Journal of Hypertension, November 2007, Wolters Kluwer Health

    Prof. Vicente Andrés

  109. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis

    Article • Cardiovascular Research, September 2007, European Society of Cardiology

    Prof. Vicente Andrés

  110. Classic and novel roles of p53: prospects for anticancer therapy

    Article • Trends in Molecular Medicine, May 2007, Elsevier

    Prof. Vicente Andrés

  111. Role of the CDKN1A/p21, CDKN1C/p57, and CDKN2A/p16 Genes in the Risk of Atherosclerosis and Myocardial Infarction

    Article • Cell Cycle, March 2007, Taylor & Francis

    Prof. Vicente Andrés

  112. Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis

    Article • Frontiers in Bioscience, January 2007, IMR Press

    Prof. Vicente Andrés

  113. Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice

    Article • Frontiers in Bioscience, January 2007, IMR Press

    Prof. Vicente Andrés

  114. Telomere Biology and Cardiovascular Disease

    Article • Circulation Research, November 2006, Wolters Kluwer Health

    Prof. Vicente Andrés

  115. Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients

    Article • Nephrology Dialysis Transplantation, July 2006, Oxford University Press (OUP)

    Prof. Vicente Andrés

  116. Cytostatic gene therapy for occlusive vascular disease

    Article • Expert Opinion on Therapeutic Patents, March 2006, Informa Healthcare

    Prof. Vicente Andrés

  117. A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C

    Article • Genes & Development, January 2006, Cold Spring Harbor Laboratory Press

    Prof. Vicente Andrés

  118. Atheroma development in apolipoprotein E-null mice is not affected by partial inactivation of PTEN

    Article • Frontiers in Bioscience, January 2006, IMR Press

    Prof. Vicente Andrés

  119. Atheroma development in apolipoprotein E‐null mice is not regulated by phosphorylation of p27Kip1 on threonine 187

    Article • Journal of Cellular Biochemistry, October 2005, Wiley

    Prof. Vicente Andrés

  120. Aging, telomeres, and atherosclerosis

    Article • Cardiovascular Research, May 2005, European Society of Cardiology

    Prof. Vicente Andrés

  121. Transcriptional profiling of early onset diet-induced atherosclerosis in apolipoprotein E-deficient mice

    Article • Frontiers in Bioscience, January 2005, Frontiers in Bioscience

    Prof. Vicente Andrés

  122. Unexpected Proatherogenic Properties of p21

    Article • Circulation, December 2004, Wolters Kluwer Health

    Prof. Vicente Andrés

  123. Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential

    Article • Cardiovascular Research, July 2004, European Society of Cardiology

    Prof. Vicente Andrés

  124. Atherogenic role of the type EIIIA fibronectin domain

    Article • Blood, July 2004, American Society of Hematology

    Prof. Vicente Andrés

  125. Role of E2F and ERK1/2 in STI571-mediated smooth muscle cell growth arrest and cyclin A transcriptional repression

    Article • Biochemical and Biophysical Research Communications, May 2004, Elsevier

    Prof. Vicente Andrés

  126. Telomeres and Cardiovascular Disease

    Article • Circulation Research, March 2004, Wolters Kluwer Health

    Prof. Vicente Andrés

  127. Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27Kip1-independent pathway

    Article • Atherosclerosis, January 2004, Elsevier

    Prof. Vicente Andrés

  128. Selective inactivation of p27Kip1 in hematopoietic progenitor cells increases neointimal macrophage proliferation and accelerates atherosclerosis

    Article • Blood, January 2004, American Society of Hematology

    Dr Antonio Diez-Juan, Prof. Vicente Andrés

  129. Article • BMC Biology, January 2004, Springer Science + Business Media

    Prof. Vicente Andrés

  130. Short telomeres protect from diet‐induced atherosclerosis in apolipoprotein E‐null mice

    Article • The FASEB Journal, December 2003, Wiley

    Prof. Vicente Andrés

  131. Optic Nerve Alterations in Apolipoprotein E Deficient Mice

    Article • European Journal of Ophthalmology, July 2003, SAGE Publications

    Prof. Vicente Andrés

  132. Cyclin-dependent protein kinases as therapeutic targets in cardiovascular disease

    Article • Expert Opinion on Therapeutic Patents, May 2003, Informa Healthcare

    Prof. Vicente Andrés

  133. Coordinate Control of Proliferation and Migration by the p27 Kip1 /Cyclin-Dependent Kinase/Retinoblastoma Pathway in Vascular Smooth Muscle Cells and Fibroblasts

    Article • Circulation Research, March 2003, Wolters Kluwer Health

    Prof. Vicente Andrés

  134. Role of the Growth Suppressor p27Kip1 During Vascular Remodeling

    Article • Current Vascular Pharmacology, March 2003, Bentham Science Publishers

    Dr Antonio Diez-Juan, Prof. Vicente Andrés

  135. Antiproliferative Strategies for the Treatment of Vascular Proliferative Disease

    Article • Current Vascular Pharmacology, March 2003, Bentham Science Publishers

    Prof. Vicente Andrés

  136. Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease

    Article • Current Pharmaceutical Biotechnology, February 2003, Bentham Science Publishers

    Prof. Vicente Andrés

  137. Distinct Regulation of Mitogen-activated Protein Kinases and p27Kip1 in Smooth Muscle Cells from Different Vascular Beds

    Article • Journal of Biological Chemistry, February 2003, Elsevier

    Prof. Vicente Andrés

  138. Increased early atherogenesis in young versus old hypercholesterolemic rabbits by a mechanism independent of arterial cell proliferation

    Article • FEBS Letters, June 2002, Wiley

    Prof. Vicente Andrés

  139. The growth suppressor p27Kip1 protects against diet-induced atherosclerosis

    Article • The FASEB Journal, September 2001, Federation of American Societies For Experimental Biology (FASEB)

    Dr Antonio Diez-Juan, Prof. Vicente Andrés

  140. Overexpression of p27Kip1by doxycycline‐regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis

    Article • The FASEB Journal, September 2001, Wiley

    Prof. Vicente Andrés

  141. Inhibition of the cyclin D1/E2F pathway by PCA‐4230, a potent repressor of cellular proliferation

    Article • British Journal of Pharmacology, April 2001, Wiley

    Prof. Vicente Andrés

  142. Role of Sp1 in the Induction of p27 Gene Expression in Vascular Smooth Muscle Cells In Vitro and After Balloon Angioplasty

    Article • Arteriosclerosis Thrombosis and Vascular Biology, March 2001, Wolters Kluwer Health

    Prof. Vicente Andrés

  143. Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases

    Article • Current Pharmaceutical Biotechnology, July 2000, Bentham Science Publishers

    Prof. Vicente Andrés

  144. Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells A potential link between aging, smooth muscle cell proliferation and atherosclerosis

    Article • Cardiovascular Research, March 2000, European Society of Cardiology

    Prof. Vicente Andrés

  145. Control of vascular smooth muscle cell growth by cyclin-dependent kinase inhibitory proteins and its implication in cardiovascular disease

    Article • Frontiers in Bioscience, January 2000, IMR Press

    Prof. Vicente Andrés

  146. Vascular smooth muscle cell growth arrest on blockade of thrombospondin-1 requires p21Cip1/WAF1

    Article • AJP Heart and Circulatory Physiology, September 1999, American Physiological Society

    Prof. Vicente Andrés

  147. Antibody Blockade of Thrombospondin Accelerates Reendothelialization and Reduces Neointima Formation in Balloon-Injured Rat Carotid Artery

    Article • Circulation, August 1999, Wolters Kluwer Health

    Prof. Vicente Andrés

  148. Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation

    Article • Biochemical Journal, August 1998, Portland Press Ltd.

    Prof. Vicente Andrés

  149. Control of vascular smooth muscle cell growth and its implication in atherosclerosis and restenosis (review).

    Article • International Journal of Molecular Medicine, July 1998, Spandidos Publications

    Prof. Vicente Andrés

  150. Nitric Oxide–Induced Downregulation of Cdk2 Activity and Cyclin A Gene Transcription in Vascular Smooth Muscle Cells

    Article • Circulation, May 1998, Wolters Kluwer Health

    Prof. Vicente Andrés

  151. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation.

    Article • Journal of Clinical Investigation, March 1998, American Society for Clinical Investigation

    Prof. Vicente Andrés

  152. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.

    Article • Journal of Clinical Investigation, May 1997, American Society for Clinical Investigation

    Prof. Vicente Andrés

  153. Embryonic Expression of the Gax Homeodomain Protein in Cardiac, Smooth, and Skeletal Muscle

    Article • Circulation Research, April 1997, Wolters Kluwer Health

    Prof. Vicente Andrés

  154. Myofibril-bound muscle phosphofructokinase is less sensitive to inhibition by ATP than the free enzyme, but retains its sensitivity to stimulation by bisphosphorylated hexoses

    Article • The International Journal of Biochemistry & Cell Biology, October 1996, Elsevier

    Prof. Vicente Andrés

  155. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis.

    Article • The Journal of Cell Biology, February 1996, Rockefeller University Press

    Prof. Vicente Andrés

  156. Determination of the Consensus Binding Site for MEF2 Expressed in Muscle and Brain Reveals Tissue-specific Sequence Constraints

    Article • Journal of Biological Chemistry, October 1995, Elsevier

    Prof. Vicente Andrés

  157. Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2.

    Article • Molecular and Cellular Biology, August 1995, ASM Journals

    Prof. Vicente Andrés

  158. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation.

    Article • Molecular and Cellular Biology, July 1995, ASM Journals

    Prof. Vicente Andrés

  159. A new bipartite DNA-binding domain: cooperative interaction between the cut repeat and homeo domain of the cut homeo proteins.

    Article • Genes & Development, January 1994, Cold Spring Harbor Laboratory Press

    Prof. Vicente Andrés

  160. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors.

    Article • Molecular and Cellular Biology, April 1993, ASM Journals

    Prof. Vicente Andrés

  161. GLUCOSE 1, 6-BISPHOSPHATE AND FRUCTOSE 2, 6-BISPHOSPHATE IN MUSCLE FROM HEALTHY HUMANS AND CHRONIC ALCOHOLIC PATIENTS

    Article • Alcohol and Alcoholism, May 1992, Oxford University Press (OUP)

    Prof. Vicente Andrés

  162. Identification of guanine and adenine nucleotides as activators of glucose-1,6-bisphosphatase activity from rat skeletal muscle

    Article • Archives of Biochemistry and Biophysics, November 1991, Elsevier

    Prof. Vicente Andrés

  163. Regulation of muscle phosphofructokinase by physiological concentrations of bisphosphorylated hexoses: Effect of alkalinization

    Article • Biochemical and Biophysical Research Communications, October 1990, Elsevier

    Prof. Vicente Andrés

  164. Effect of denervation on the distribution and developmental transition of phosphoglycerate mutase and creatine phosphokinase isozymes in rat muscles of different fiber-type composition

    Article • Differentiation, April 1990, Elsevier

    Prof. Vicente Andrés

  165. Distribution and developmental transition of phosphoglycerate mutase and creatine phosphokinase isozymes in rat muscles of different fiber-type composition

    Article • Differentiation, July 1989, Elsevier

    Prof. Vicente Andrés

  166. Allosteric inhibition of Dictyostelium discoideum fructose‐1,6‐bisphosphatase by fructose 2,6‐bisphosphate

    Article • FEBS Letters, December 1988, Wiley

    Prof. Vicente Andrés

  167. Activation of muscle phosphofructokinase by α-glucose 1,6-bisphosphate and fructose 2,6-bisphosphate is differently affected by other allosteric effectors and by pH

    Article • Biochemical and Biophysical Research Communications, December 1988, Elsevier

    Prof. Vicente Andrés